An internal DHS document reveals how data collected by the advertsing industry could be used for government surveillance.

Highest maturity classification underscores GFT’s ability to embed AI directly into the execution layer of large-scale, ...

Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...

As drug development becomes more complex, so do the demands for accurate, reproducible bioanalytical data to prove their safety and efficacy. Method validation ensures the reliability of ...

Explore SLAS Boston 2026 insights on connecting laboratory automation and data infrastructure in drug discovery workflows.

Pantera Capital and Franklin Templeton support Sentient's Arena platform, designed to benchmark AI agent performance on complex enterprise document tasks.

That's the industry's next test, and what should be the big topic of conversation at HIMSS26, says the health technology lead at Accenture. Every AI deployment should be tied to measurable ops or ...

AI agents are fast, loose, and out of control, MIT study finds ...

The Monetary Authority of Singapore (MAS) positions AI squarely within supervisory oversight, embedding governance accountability, lifecycle controls, and structured materiality into financial ...

A discussion of the current landscape of generative AI (GenAI) patent drafting tools, including the differences between fully ...

Are AGENTS.md files actually helping your AI coding agents, or are they making them stupider? We dive into new research from ETH Zurich, real-world experiments, and security risks to find the truth ...